1cP-AL-LAD is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is thought to act as prodrug of AL-LAD. The drug has been encountered as a novel designer drug.
Use and effects
The dose of 1cP-AL-LAD ranges from 20 to 350μg orally, with an average dose being 100 to 225μg. Its duration is said to be 7 to 10hours. The drug is said to produce psychedelic effects that are weaker and shorter-lasting than those of LSD.
Interactions
Chemistry Analogues Related compounds include 1cP-LSD, 1D-LSD, 1P-AL-LAD, and 1T-AL-LAD, among others.
History 1cP-AL-LAD has been sold as a designer drug. It was first identified online in December 2020 and in France in June 2021.
Society and culture Legal status Canada 1cP-AL-LAD is not a controlled substance in Canada as of 2025.
United States 1cP-AL-LAD is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
See also Substituted lysergamide Lizard Labs
References
External links 1cP-AL-LAD - Isomer Design 1cP-AL-LAD - PsychonautWiki